Focal nodular hyperplasia and hepatic adenoma: Epidemiology and pathology

Digestive Surgery

Volumn 27, Issue 1, 2010, Pages 24-31

  Maillette De Buy Wenniger, Lucas ^a   Terpstra, Valeska ^a   Beuers, Ulrich ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Benign liver lesion; Focal nodular hyperplasia; Hepatic adenoma; Hepatic tumor

Indexed keywords

ADENOMA; ARTICLE; FEMALE; HUMAN; LIVER TUMOR; NODULAR HYPERPLASIA; PATHOLOGY;

ADENOMA; FEMALE; FOCAL NODULAR HYPERPLASIA; HUMANS; LIVER NEOPLASMS;

EID: 77950540496     PISSN: 02534886     EISSN: None     Source Type: Journal    
DOI: 10.1159/000268404     Document Type: Article

References (48)

1. Wanless IR, Albrecht S, Bilbao J, Frei JV, Heathcote EJ, Roberts EA, Chiasson D: Multiple focal nodular hyperplasia of the liver associated with vascular malformations of various organs and neoplasia of the brain: a new syndrome. Mod Pathol 1989; 2: 456-462.
2. Rebouissou S, Bioulac-Sage P, Zucman-Rossi J: Molecular pathogenesis of focal nodular hyperplasia and hepatocellular adenoma. J Hepatol 2008; 48: 163-170. (Pubitemid 350199576)
3. Vilgrain V, Uzan F, Brancatelli G, Federle MP, Zappa M, Menu Y: Prevalence of hepatic hemangioma in patients with focal nodular hyperplasia: MRI analysis. Radiology 2003; 229: 75-79. (Pubitemid 37152108)
4. Buscarini E, Danesino C, Plauchu H, de Fazio C, Olivieri C, Brambilla G, Menozzi F, et al: High prevalence of hepatic focal nodular hyperplasia in subjects with hereditary hemorrhagic telangiectasia. Ultrasound Med Biol 2004; 30: 1089-1097. (Pubitemid 39531615)
5. Libbrecht L, Cassiman D, Verslype C, Maleux G, Van Hees D, Pirenne J, Nevens F, et al: Clinicopathological features of focal nodular hyperplasia-like nodules in 130 cirrhotic explant livers. Am J Gastroenterol 2006; 101: 2341-2346. (Pubitemid 44477563)
6. Turowski C, Feist H, Alzen G, Gluer S, Petersen C: Conversion of a neonatal hepatic hemangioma to focal nodular hyperplasia. Pathol Int 2009; 59: 251-254.
7. Sudour H, Mainard L, Baumann C, Clement L, Salmon A, Bordigoni P: Focal nodular hyperplasia of the liver following hematopoietic SCT. Bone Marrow Transplant 2009; 43: 127-132.
8. Bouyn CI, Leclere J, Raimondo G, Le Pointe HD, Couanet D, Valteau-Couanet D, Hartmann O: Hepatic focal nodular hyperplasia in children previously treated for a solid tumor. Incidence, risk factors, and outcome. Cancer 2003; 97: 3107-3113. (Pubitemid 36676267)
9. Nguyen BN, Flejou JF, Terris B, Belghiti J, Degott C: Focal nodular hyperplasia of the liver: a comprehensive pathologic study of 305 lesions and recognition of new histologic forms. Am J Surg Pathol 1999; 23: 1441-1454.
10. Weimann A, Ringe B, Klempnauer J, Lamesch P, Gratz KF, Prokop M, Maschek H, et al: Benign liver tumors: differential diagnosis and indications for surgery. World J Surg 1997; 21: 983-990. (Pubitemid 27465542)
11. Cherqui D, Rahmouni A, Charlotte F, Boulahdour H, Metreau JM, Meignan M, Fagniez PL, et al: Management of focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological, and pathological correlations. Hepatology 1995; 22: 1674-1681.
12. Hussain SM, Terkivatan T, Zondervan PE, Lanjouw E, de Rave S, Ijzermans JN, de Man RA: Focal nodular hyperplasia: findings at state-of-the-art MRI, US, CT, and pathologic analysis. Radiographics 2004; 24: 3-19. (Pubitemid 38134587)
13. Van den Esschert JW, van Gulik TM, Phoa SSKS: Imaging modalities for focal nodular hyperplasia and hepatocellular adenoma. Dig Surg 2010;27:46-55.
14. Strobel D, Seitz K, Blank W, Schuler A, Dietrich CF, von Herbay A, Friedrich-Rust M, et al: Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound. Ultraschall Med 2009; 30: 376-382.
15. Trillaud H, Bruel JM, Valette PJ, Vilgrain V, Schmutz G, Oyen R, Jakubowski W, et al: Characterization of focal liver lesions with SonoVue-enhanced sonography: international multicenter study in comparison to CT and MRI. World J Gastroenterol 2009; 15: 3748-3756.
16. Assy N, Nasser G, Djibre A, Beniashvili Z, Elias S, Zidan J: Characteristics of common solid liver lesions and recommendations for diagnostic workup. World J Gastroenterol 2009; 15: 3217-3227.
17. Descottes B, Glineur D, Lachachi F, Valleix D, Paineau J, Hamy A, Morino M, et al: Laparoscopic liver resection of benign liver tumors. Surg Endosc 2003; 17: 23-30.
18. Koffron AJ, Auffenberg G, Kung R, Abecassis M: Evaluation of 300 minimally invasive liver resections at a single institution: less is more. Ann Surg 2007; 246: 385-392. (Pubitemid 47312124)
19. Karhunen PJ: Benign hepatic tumours and tumour-like conditions in men. J Clin Pathol 1986; 39: 183-188.
20. Cherqui D, Mathieu D, Zafrani ES, Dhumeaux D: Focal nodular hyperplasia and hepatocellular adenoma in women. Current data (in French). Gastroenterol Clin Biol 1997; 21: 929-935. (Pubitemid 28078777)
21. Wanless IR: Micronodular transformation (nodular regenerative hyperplasia) of the liver: a report of 64 cases among 2,500 autopsies and a new classification of benign hepatocellular nodules. Hepatology 1990; 11: 787-797.
22. Litten JB, Tomlinson GE: Liver tumors in children. Oncologist 2008; 13: 812-820.
23. Meyers RL: Tumors of the liver in children. Surg Oncol 2007; 16: 195-203.
24. Colombo M, Lencioni R, Rodes J, et al: (eds): Textbook of Hepatology. Oxford, Oxford University Press, 2008, p 1428.
25. Ungermann L, Elias P, Zizka J, Ryska P, Klzo L: Focal nodular hyperplasia: spoke-wheel arterial pattern and other signs on dynamic contrast-enhanced ultrasonography. Eur J Radiol 2007; 63: 290-294. (Pubitemid 47239265)
26. Paradis V, Benzekri A, Dargere D, Bieche I, Laurendeau I, Vilgrain V, Belghiti J, et al: Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology 2004; 126: 1323-1329. (Pubitemid 38559002)
27. Bioulac-Sage P, Balabaud C, Bedossa P, Scoazec JY, Chiche L, Dhillon AP, Ferrell L, et al: Pathological diagnosis of liver cell adenoma and focal nodular hyperplasia: Bordeaux update. J Hepatol 2007; 46: 521-527. (Pubitemid 46201719)
28. Paradis V, Laurent A, Flejou JF, Vidaud M, Bedossa P: Evidence for the polyclonal nature of focal nodular hyperplasia of the liver by the study of X-chromosome inactivation. Hepatology 1997; 26: 891-895. (Pubitemid 27413654)
29. Paradis V, Champault A, Ronot M, Deschamps L, Valla DC, Vidaud D, Vilgrain V, et al: Telangiectatic adenoma: an entity associated with increased body mass index and inflammation. Hepatology 2007; 46: 140-146. (Pubitemid 47171930)
30. Chen YW, Jeng YM, Yeh SH, Chen PJ: P53 gene and Wnt signaling in benign neoplasms: β-catenin mutations in hepatic adenoma but not in focal nodular hyperplasia. Hepatology 2002; 36: 927-935.
31. Rebouissou S, Couchy G, Libbrecht L, Balabaud C, Imbeaud S, Auffray C, Roskams T, et al: The β-catenin pathway is activated in focal nodular hyperplasia but not in cirrhotic FNH-like nodules. J Hepatol 2008; 49: 61-71.
32. Paradis V, Bieche I, Dargere D, Laurendeau I, Nectoux J, Degott C, Belghiti J, et al: A quantitative gene expression study suggests a role for angiopoietins in focal nodular hyperplasia. Gastroenterology 2003; 124: 651-659. (Pubitemid 36268484)
33. Haninec AL, Voskas D, Needles A, Brown AS, Foster FS, Dumont DJ: Transgenic expression of angiopoietin-1 in the liver leads to changes in lymphatic and blood vessel architecture. Biochem Biophys Res Commun 2006; 345: 1299-1307. (Pubitemid 43817876)
34. Rooks JB, Ory HW, Ishak KG, Strauss LT, Greenspan JR, Hill AP, Tyler CW Jr: Epidemiology of hepatocellular adenoma. The role of oral contraceptive use. JAMA 1979; 242: 644-648.
35. Giannitrapani L, Soresi M, La Spada E, Cervello M, D'Alessandro N, Montalto G: Sex hormones and risk of liver tumor. Ann NY Acad Sci 2006; 1089: 228-236. (Pubitemid 47092098)
36. Socas L, Zumbado M, Perez-Luzardo O, Ramos A, Perez C, Hernandez JR, Boada LD: Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature. Br J Sports Med 2005; 39:e27.
37. Nakao A, Sakagami K, Nakata Y, Komazawa K, Amimoto T, Nakashima K, Isozaki H, et al: Multiple hepatic adenomas caused by long-term administration of androgenic steroids for aplastic anemia in association with familial adenomatous polyposis. J Gastroenterol 2000; 35: 557-562. (Pubitemid 30468464)
38. Triantafyllopoulou M, Whitington PF, Melin- Aldana H, Benya EC, Brickman W: Hepatic adenoma in an adolescent with elevated androgen levels. J Pediatr Gastroenterol Nutr 2007; 44: 640-642. (Pubitemid 46684370)
39. Grange JD, Guechot J, Legendre C, Giboudeau J, Darnis F, Poupon R: Liver adenoma and focal nodular hyperplasia in a man with high endogenous sex steroids. Gastroenterology 1987; 93: 1409-1413. (Pubitemid 17167286)
40. Beuers U, Richter WO, Ritter MM, Wiebecke B, Schwandt P: Klinefelter's syndrome and liver adenoma. J Clin Gastroenterol 1991; 13: 214-216.
41. Labrune P, Trioche P, Duvaltier I, Chevalier P, Odievre M: Hepatocellular adenomas in glycogen storage disease type I and III: a series of 43 patients and review of the literature. J Pediatr Gastroenterol Nutr 1997; 24: 276-279. (Pubitemid 27199615)
42. Greaves WO, Bhattacharya B: Hepatic adenomatosis. Arch Pathol Lab Med 2008; 132: 1951-1955.
43. Terkivatan T, de Wilt JH, de Man RA, van Rijn RR, Zondervan PE, Tilanus HW, JN IJ: Indications and long-term outcome of treatment for benign hepatic tumors: a critical appraisal. Arch Surg 2001; 136: 1033-1038. (Pubitemid 32982993)
44. Cho SW, Marsh JW, Steel J, Holloway SE, Heckman JT, Ochoa ER, Geller DA, et al: Surgical management of hepatocellular adenoma: take it or leave it? Ann Surg Oncol 2008; 15: 2795-2803.
45. Bioulac-Sage P, Blanc JF, Rebouissou S, Balabaud C, Zucman-Rossi J: Genotype phenotype classification of hepatocellular adenoma. World J Gastroenterol 2007; 13: 2649-2654. (Pubitemid 46958719)
46. Bioulac-Sage P, Balabaud C, Zucman-Rossi J: Subtype classification of hepatocellular adenoma. Dig Surg 2010;27:39-45 .
47. Zucman-Rossi J, Jeannot E, Nhieu JT, Scoazec JY, Guettier C, Rebouissou S, Bacq Y, et al: Genotype-phenotype correlation in hepatocellular adenoma: new classification and relationship with HCC. Hepatology 2006; 43: 515-524.
48. Bluteau O, Jeannot E, Bioulac-Sage P, Marques JM, Blanc JF, Bui H, Beaudoin JC, et al: Biallelic inactivation of TCF1 in hepatic adenomas. Nat Genet 2002; 32: 312-315.